BioCentury
ARTICLE | Clinical News

MCLA-117: Phase I/II started

May 16, 2016 7:00 AM UTC

Merus began an open-label, dose-escalation, international Phase I/II trial to evaluate MCLA-117 in up to 50 patients. The trial will enroll patients with relapsed or refractory AML and those aged >65 ...